What is OS Therapies's investing cash flow?

OS Therapies (OSTX) reported investing cash flow of -$292.79K in Q2 2025.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

OS Therapies OSTX Investing Cash Flow

Investing Cash Flow at other companies

ImmunomeIMNM

-$12.02M-336%

CTO

Citius Oncology, Inc.CTOR

-$600K+58.3%

Avalo TherapeuticsAVTX

$25.51M—

Arcus BiosciencesRCUS

$114M+256%

ImmunityBio, Inc.IBRX

-$31.65M-867%

WHW

Whitehawk Therapeutics, Inc. Common StockWHWK

$19.43M-83.2%

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+66.4%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: OS Therapies’s 10-Q, filed August 18, 2025, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's investing cash flow?: OS Therapies (OSTX) reported investing cash flow of -$292.79K in Q2 2025.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.